# Thrombin+calcium chloride+aprotinin+protein clotta

## Tisseel solution for sealant 4mL/set

| TAH Drug Code      | [ETIS4](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ETIS4){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Adjunct to hemostasis in cardiopulmonary bypass surgery (including fully heparinized patients) and splenic injury (due to blunt or penetrating trauma to the abdomen) when the control of bleeding by conventional surgical techniques is ineffective or impractical; adjunctive sealant for closure of colostomies.                                                                                                                                                                                             |
| Dosing             | 2mL of TISSEEL, which means 1mL TISSEEL and 1mL of thrombin solution, could cover at least 10cm2, depending on surgery type, wound size and frequency.                                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypersensitivity to aprotinin; direct intravascular injection; severe or brisk arterial bleeding                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | May be related to aprotinin contained in some products. Frequency may vary by product. 1% to 10%: Cardiovascular: Bradycardia (?10%) Central nervous system: Fever (6%) Dermatologic: Pruritus Gastrointestinal: Abdominal distension (4%) Hematologic & oncologic: Hematoma (Facial rhytidectomy: 1% to 4%), hemorrhage (internal, postprocedural; 2%), increased serum fibrinogen (2%) Immunologic: Antibody development (1% to 2%) Local: Skin graft failure (3%) Respiratory: Pulmonary embolism (<1% to 3%) |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| More Info          | [UpToDate](https://www.uptodate.com/contents/thrombin+calcium-chloride+aprotinin+protein-clotta-drug-information){:target="_blank"}                                                                                                                                                                                                                                                                                                                                                                              |

